Joost Daemen
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study (NCT04591938) | Joost Daemen | 2019-10-01 |
Track Joost Daemen automatically
Every clearance here is in the API, with alerts when new ones post.